de Geus-Oei LF - Search Results

1

Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.

Meijer TW, Schuurbiers OC, Kaanders JH, Looijen-Salamon MG, de Geus-Oei LF, Verhagen AF, Lok J, van der Heijden HF, Rademakers SE, Span PN, Bussink J. Meijer TW, et al. Lung Cancer. 2012 Jun;76(3):316-23. doi: 10.1016/j.lungcan.2011.11.006. Epub 2011 Dec 6. Lung Cancer. 2012. PMID: 22153830

2

Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.

van Laarhoven HW, de Geus-Oei LF, Wiering B, Lok J, Rijpkema M, Kaanders JH, Krabbe PF, Ruers T, Punt CJ, van der Kogel AJ, Oyen WJ, Heerschap A. van Laarhoven HW, et al. Radiology. 2005 Oct;237(1):181-8. doi: 10.1148/radiol.2371041397. Radiology. 2005. PMID: 16183932

3

Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer.

de Geus-Oei LF, Kaanders JH, Pop LA, Corstens FH, Oyen WJ. de Geus-Oei LF, et al. Radiother Oncol. 2006 Jul;80(1):51-6. doi: 10.1016/j.radonc.2006.06.001. Epub 2006 Jul 3. Radiother Oncol. 2006. PMID: 16820237

4

Biological correlates of FDG uptake in non-small cell lung cancer.

de Geus-Oei LF, van Krieken JH, Aliredjo RP, Krabbe PF, Frielink C, Verhagen AF, Boerman OC, Oyen WJ. de Geus-Oei LF, et al. Lung Cancer. 2007 Jan;55(1):79-87. doi: 10.1016/j.lungcan.2006.08.018. Epub 2006 Oct 13. Lung Cancer. 2007. PMID: 17046099

5

Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.

de Geus-Oei LF, van der Heijden HF, Visser EP, Hermsen R, van Hoorn BA, Timmer-Bonte JN, Willemsen AT, Pruim J, Corstens FH, Krabbe PF, Oyen WJ. de Geus-Oei LF, et al. J Nucl Med. 2007 Oct;48(10):1592-8. doi: 10.2967/jnumed.107.043414. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873138 Free article. Clinical Trial.

6

Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.

de Geus-Oei LF, van der Heijden HF, Corstens FH, Oyen WJ. de Geus-Oei LF, et al. Cancer. 2007 Oct 15;110(8):1654-64. doi: 10.1002/cncr.22979. Cancer. 2007. PMID: 17879371 Free article. Review.

7

Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.

Visser EP, Philippens ME, Kienhorst L, Kaanders JH, Corstens FH, de Geus-Oei LF, Oyen WJ. Visser EP, et al. J Nucl Med. 2008 Jun;49(6):892-8. doi: 10.2967/jnumed.107.049585. Epub 2008 May 15. J Nucl Med. 2008. PMID: 18483085 Free article.

8

The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.

Dijkman BG, Schuurbiers OC, Vriens D, Looijen-Salamon M, Bussink J, Timmer-Bonte JN, Snoeren MM, Oyen WJ, van der Heijden HF, de Geus-Oei LF. Dijkman BG, et al. Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2037-47. doi: 10.1007/s00259-010-1505-2. Epub 2010 Jun 10. Eur J Nucl Med Mol Imaging. 2010. PMID: 20533031 Free PMC article.

9

Comparison of two region of interest definition methods for metabolic response evaluation with [18F]FDG-PET.

Vriens D, De Geus-Oei LF, Van Laarhoven HW, Van Der Heijden HF, Krabbe PF, Visser EP, Oyen WJ. Vriens D, et al. Q J Nucl Med Mol Imaging. 2010 Sep 8. Online ahead of print. Q J Nucl Med Mol Imaging. 2010. PMID: 20827254

10

Comparison of two region of interest definition methods for metabolic response evaluation with [¹⁸F]FDG-PET.

Vriens D, De Geus-Oei LF, Van Laarhoven HW, Van Der Heijden HF, Krabbe PF, Visser EP, Oyen WJ. Vriens D, et al. Q J Nucl Med Mol Imaging. 2010 Dec;54(6):677-88. Q J Nucl Med Mol Imaging. 2010. PMID: 21221073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters